AbstractGet full access to this articleView all access options for this article.Get accessReferences1. Lamarca A Palmer DH Wasan HS , et al. Second-line FOLFOX chemotherapy versus active symptom control for advanced biliary tract cancer (ABC-06): a phase 3, open-label, randomised, controlled trial. Lancet Oncol 2021; 22: 690–701.